Management of epilepsy in tuberous sclerosis complex. (Q46697537)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18345974%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

title

Management of epilepsy in tuberous sclerosis complex (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18345974%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18345974%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

author name string

P Curatolo

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18345974%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

C Cerminara

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18345974%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

R Bombardieri

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18345974%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

publication date

1 March 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18345974%20AND%20SRC:MED&resulttype=core&format=json

Expert Review of Neurotherapeutics: a key contribution to decision making in the treatment of neurologic and neuropsychiatric disorders

4 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18345974%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

volume

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18345974%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18345974%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

page(s)

457-467

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18345974%20AND%20SRC:MED&resulttype=core&format=json

Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34

4 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.3.457

Identification and characterization of the tuberous sclerosis gene on chromosome 16

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.3.457

Mutational analysis in a cohort of 224 tuberous sclerosis patients indicates increased severity of TSC2, compared with TSC1, disease in multiple organs

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.3.457

Comprehensive mutation analysis of TSC1 and TSC2-and phenotypic correlations in 150 families with tuberous sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.3.457

Mutational analysis of TSC1 and TSC2 in Korean patients with tuberous sclerosis complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.3.457

Molecular and clinical analyses of 84 patients with tuberous sclerosis complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.3.457

Tuberous sclerosis complex: clinical features, diagnosis, and prevalence within Northern Ireland.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.3.457

The tuberous sclerosis complex and its highly variable manifestations

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.3.457

Prevalence of tuberous sclerosis estimated by capture-recapture analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.3.457

Tuberous sclerosis complex in Olmsted County, Minnesota, 1950-1989.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.3.457

Cardiac rhabdomyomas and their association with tuberous sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.3.457

Tuberous sclerosis complex: a review of neurological aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.3.457

The tuberous sclerosis complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.3.457

Intractable seizures in tuberous sclerosis complex: from molecular pathogenesis to the rationale for treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.3.457

Pathogenesis of tuberous sclerosis subependymal giant cell astrocytomas: biallelic inactivation of TSC1 or TSC2 leads to mTOR activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.3.457

The tuberous sclerosis complex proteins--a GRIPP on cognition and neurodevelopment

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.3.457

Longitudinal MR findings in a patient with hemimegalencephaly associated with tuberous sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.3.457

Integrative classification of morphology and molecular genetics in central nervous system malformations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.3.457

Mechanisms of epileptogenesis in tuberous sclerosis complex and related malformations of cortical development with abnormal glioneuronal proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.3.457

Neuroimaging in tuberous sclerosis complex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.3.457

Increased brain apparent diffusion coefficient in tuberous sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.3.457

Neuropsychiatric aspects of tuberous sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.3.457

Topographic comparative study of magnetic resonance imaging and electroencephalography in 34 children with tuberous sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.3.457

Frontal lobe epilepsy associated with tuberous sclerosis: electroencephalographic-magnetic resonance image fusioning

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.3.457

The relation of infantile spasms, tubers, and intelligence in tuberous sclerosis complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.3.457

Mental and behavioural outcome of infantile epilepsy treated by vigabatrin in tuberous sclerosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.3.457

Current management for epilepsy in tuberous sclerosis complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.3.457

Sleep disorders in tuberous sclerosis: a polysomnographic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.3.457

Selective alterations in glutamate and GABA receptor subunit mRNA expression in dysplastic neurons and giant cells of cortical tubers

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.3.457

Dysfunction of synaptic inhibition in epilepsy associated with focal cortical dysplasia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.3.457

Anomalous inhibitory circuits in cortical tubers of human tuberous sclerosis complex associated with refractory epilepsy: aberrant expression of parvalbumin and calbindin-D28k in dysplastic cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.3.457

Disruption of interneuron development

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.3.457

Regulation of neocortical interneuron development and the implications for neurodevelopmental disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.3.457

Physiological modulation of GABA(A) receptor plasticity by progesterone metabolites.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.3.457

GABA(A) receptor active steroids are altered in epilepsy patients with tuberous sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.3.457

Vigabatrin in the treatment of infantile spasms in tuberous sclerosis: literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.3.457

Current role of vigabatrin in infantile spasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.3.457

Impaired glial glutamate transport in a mouse tuberous sclerosis epilepsy model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.3.457

Neocortical hyperexcitability in a human case of tuberous sclerosis complex and mice lacking neuronal expression of TSC1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.3.457

Roles of glutamate receptors and the mammalian target of rapamycin (mTOR) signaling pathway in activity-dependent dendritic protein synthesis in hippocampal neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.3.457

A role for the mTOR pathway in surface expression of AMPA receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.3.457

Characteristics of epilepsy in focal cortical dysplasia in infancy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.3.457

Taylor-type focal cortical dysplasia in infants: some MRI lesions almost disappear with maturation of myelination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.3.457

Focal cortical dysplasia: neuropathological subtypes, EEG, neuroimaging and surgical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.3.457

Visual field defects in pediatric patients on vigabatrin monotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.3.457

Severe persistent visual field constriction associated with vigabatrin

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.3.457

Another case of reversibility of visual-field defect induced by vigabatrin monotherapy: is young age a favorable factor?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.3.457

Visual field constriction in children with epilepsy on vigabatrin treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.3.457

Visual field defects associated with vigabatrin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.3.457

Vigabatrin-associated visual field defects in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.3.457

Examining visual field defects in the paediatric population exposed to vigabatrin

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.3.457

Visual field constriction in 91 Finnish children treated with vigabatrin

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.3.457

Reversed visual field constrictions in children after vigabatrin withdrawal--true retinal recovery or improved test performance only?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.3.457

Characterization of vigabatrin‐associated optic atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.3.457

Characteristics of a unique visual field defect attributed to vigabatrin

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.3.457

Visual field loss associated with vigabatrin: pathological correlations

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.3.457

Vigabatrin-associated loss of vision: rarebit perimetry illuminates the dose-damage relationship

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.3.457

Evidence-based treatment of idiopathic generalized epilepsies with new antiepileptic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.3.457

Vigabatrin retinopathy in an Irish cohort: lack of correlation with dose.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.3.457

The natural history of Vigabatrin associated visual field defects in patients electing to continue their medication

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.3.457

Characteristic retinal atrophy with secondary "inverse" optic atrophy identifies vigabatrin toxicity in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.3.457

Electro-oculography, electroretinography, visual evoked potentials, and multifocal electroretinography in patients with vigabatrin-attributed visual field constriction

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.3.457

Alterations in electroretinograms and retinal morphology in rabbits treated with vigabatrin

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.3.457

Scotopic threshold response changes after vigabatrin therapy in a child without visual field defects: a new electroretinographic marker of early damage?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.3.457

Consistent localization of interictal epileptiform activity on EEGs of patients with tuberous sclerosis complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.3.457

Identification of candidates for epilepsy surgery in patients with tuberous sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.3.457

Characterizing magnetoencephalographic spike sources in children with tuberous sclerosis complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.3.457

Imaging epileptogenic tubers in children with tuberous sclerosis complex using alpha-[11C]methyl-L-tryptophan positron emission tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.3.457

Epilepsy surgery outcome in children with tuberous sclerosis complex evaluated with alpha-[11C]methyl-L-tryptophan positron emission tomography (PET).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.3.457

Epilepsy surgery for tuberous sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.3.457

Epilepsy surgery in tuberous sclerosis: multistage procedures with bilateral or multilobar foci.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.3.457

Tuberous sclerosis and multiple tubers: localizing the epileptogenic zone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.3.457

Epilepsy surgery in tuberous sclerosis: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.3.457

Tuberous sclerosis complex and the ketogenic diet

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.3.457

Vagus nerve stimulation: clinical experience in drug-resistant pediatric epileptic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.3.457

Vagal nerve stimulation in tuberous sclerosis complex patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.3.457

Antitumoral activity of rapamycin in renal angiomyolipoma associated with tuberous sclerosis complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.3.457

Rapamycin causes regression of astrocytomas in tuberous sclerosis complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.3.457

21 January 2018

Identifiers

DOI

10.1586/14737175.8.3.457

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18345974%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

1 reference